Day Trade Watchlist:
SCTY, PLUG, MBLY , MEI, INFI , CIEN , MFRM , PAY , NLNK, TASR , SUNE, YUM , MTRX , NAV, ABM, IO , ABBV, PVH
SCTY, PLUG, MBLY , MEI, INFI , CIEN , MFRM , PAY , NLNK, TASR , SUNE, YUM , MTRX , NAV, ABM, IO , ABBV, PVH
Volatile Stock
(Risky Stock): STXS,
News that matter:
Mitek Systems and USAA
settle lawsuit Neither party admits liability on any claim, and
neither party is making any payment to the other. USAA is retaining its license
to use Mitek's Quick Strokes, Quick FX Pro, and Image Score software products. (MITK)
SunEdison and Los
Pelambres Mine (Antofagasta Minerals) close an agreement to supply solar
electric power in Chile (SUNE)
ABM Industries beats by
$0.01, reports revs in-line; raises FY14 EPS guidance above consensus (ABM)
Matrix Service misses
by $0.08, misses on revs; guides FY15 EPS below consensus, revs in-line (MTRX)
YUM! Brands discloses
significant, negative impact to sales at both KFC and Pizza Hut in China; sees
Q3 SSS -13% (YUM)
Novavax to present RSV
vaccine clinical and preclinical results on September 6-7 (NVAX)
STMicroelectronics and
Tessera (TSRA) settle pending litigation; terms of the
agreement are confidential (STM)
Kamada to announce the
final results from its European Phase 2/3 clinical trial of its proprietary
inhaled alpha-1 antitrypsin to treat alpha-1 antitrypsin deficiency on
Thursday, Sept 4, 2014 at approx. 7:00am ET (KMDA)
Eclipse Resources
announces the commencement of production at two of the Co's pad locations
consisting of a total of 7 Utica Shale wells; co reaffirms production guidance
for Q3; co believes it will produce average daily production during Q3 at, or
above, the mid-point of its guidance (ECR)
Shoe Carnival misses by
$0.02, misses on revs; guides Q3 EPS below consensus, revs below consensus;
guides Q4 (Jan) EPS in-line, revs in-line; Q2 comps -2.1% (SCVL)
PVH beats by $0.09,
reports revs in-line; guides Q3 EPS in-line, revs below consensus; reaffirms
FY15 EPS guidance, lowers FY15 rev guidance slightly (PVH)
AbbVie reaffirms FY14
adjusted EPS guidance of $3.06-3.16 vs $3.15 Capital IQ Consensus Estimate;
reaffirms Q3 adjusted EPS guidance of $0.77-0.79 vs $0.77 Capital IQ Consensus
Estimate (ABBV)
Flexion Therapeutics to
start FX006 Phase 3 Pivotal Trial in 2014; following FDA meeting, development
plan advanced by one year (FLXN)
H & R Block misses
by $0.02, beats on revs (HRB)
Bolt Technology to be
acquired by Teledyne (TDY) for $22 per share in cash (stock halted) (BOLT) (IO), (DWSN)
Bazaarvoice beats by
$0.03, beats on revs (BV)
Chart of the day:
AAPL:
MFRM: Past earning performance on earning day 6%, 7%, 15%, -17%, CITI reaffirms to $63 PT. Chart Indicates bearish crossover
 |
| MFRM Pre earning preview |
JOY:
 |
| JOY |
 |
| PAY |
No comments:
Post a Comment